The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy: A Randomized Trial
Open accessAbstract
CONTEXT: Despite reported success, surgery for pharmacoresistant seizures is often seen as a last resort. Patients are typically referred for surgery after 20 years of seizures, often too late to avoid significant disability and premature death. OBJECTIVE: We sought to determine whether surgery soon after failure of 2 antiepileptic drug (AED) trials is superior to continued medical management in controlling seizures and improving quality of life (QOL). DESIGN, SETTING, AND PARTICIPANTS: The Early Randomized Surgical Epilepsy Trial (ERSET) is a multicenter, controlled, parallel-group clinical trial performed at 16 US epilepsy surgery centers. The 38 participants (18 men and 20 women; aged ≥12 years) had mesial temporal lobe epilepsy (MTLE) and disabling seizues for no more than 2 consecutive years following adequate trials of 2 brand-name AEDs. Eligibility for anteromesial temporal resection (AMTR) was based on a standardized presurgical evaluation protocol. Participants were randomized to continued AED treatment or AMTR 2003-2007, and observed for 2 years. Planned enrollment was 200, but the trial was halted prematurely due to slow accrual. INTERVENTION: Receipt of continued AED treatment (n = 23) or a standardized AMTR plus AED treatment (n = 15). In the medical group, 7 participants underwent AMTR prior to the end of follow-up and 1 participant in the surgical group never received surgery. MAIN OUTCOME MEASURES: The primary outcome variable was freedom from disabling seizures during year 2 of follow-up. Secondary outcome variables were health-related QOL (measured primarily by the 2-year change in the Quality of Life in Epilepsy 89 [QOLIE-89] overall T-score), cognitive function, and social adaptation. RESULTS: Zero of 23 participants in the medical group and 11 of 15 in the surgical group were seizure free during year 2 of follow-up (odds ratio = ∞; 95% CI, 11.8 to ∞; P < .001). In an intention-to-treat analysis, the mean improvement in QOLIE-89 overall T-score was higher in the surgical group than in the medical group but this difference was not statistically significant (12.6 vs 4.0 points; treatment effect = 8.5; 95% CI, -1.0 to 18.1; P = .08). When data obtained after surgery from participants in the medical group were excluded, the effect of surgery on QOL was significant (12.8 vs 2.8 points; treatment effect = 9.9; 95% CI, 2.2 to 17.7; P = .01). Memory decline (assessed using the Rey Auditory Verbal Learning Test) occurred in 4 participants (36%) after surgery, consistent with rates seen in the literature; but the sample was too small to permit definitive conclusions about treatment group differences in cognitive outcomes. Adverse events included a transient neurologic deficit attributed to a magnetic resonance imaging-identified postoperative stroke in a participant who had surgery and 3 cases of status epilepticus in the medical group. CONCLUSIONS: Among patients with newly intractable disabling MTLE, resective surgery plus AED treatment resulted in a lower probability of seizures during year 2 of follow-up than continued AED treatment alone. Given the premature termination of the trial, the results should be interpreted with appropriate caution. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00040326.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Allen Hauser, W., Mathern, G., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,877
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Epilepsy
Wiebe, S., Blume, W. T., Girvin, J. P., & Eliasziw, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450501 · Cited by 3,525
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278
Reynolds, C. R., & Powel, J. (1988) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/3.4.397 · Cited by 2,095
Procedures for Comparing Samples with Multiple Endpoints
O'Brien, P. C. (1984) · Biometrics · doi:10.2307/2531158 · Cited by 1,162
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,113
Engel, J., Wiebe, S., French, J., Sperling, M., Williamson, P., Spencer, D., Gumnit, R., Zahn, C., Westbrook, E., & Enos, B. (2003) · Neurology · doi:10.1212/01.wnl.0000055086.35806.2d · Cited by 904
Self-citationMesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Compiled by Heinz‐Gregor Wieser for the ILAE Commission on Neurosurgery of Epilepsy (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.09004.x · Cited by 773
Development of the Quality of Life in Epilepsy Inventory
Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., & Hays, R. D. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00467.x · Cited by 634
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Reporting of Patient-Reported Outcomes in Randomized Trials: The CONSORT PRO Extension
Calvert, M., Blazeby, J., Altman, D. G., Revicki, D. A., Moher, D., Brundage, M. D., & CONSORT PRO Group, F. T. (2013) · JAMA · doi:10.1001/jama.2013.879 · Cited by 1,386
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
Blumcke, I., Spreafico, R., Haaker, G., Coras, R., Kobow, K., Bien, C. G., Pfäfflin, M., Elger, C., Widman, G., Schramm, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703784 · Cited by 931
Moshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
Salanova, V., Witt, T., Worth, R., Henry, T. R., Gross, R. E., Nazzaro, J. M., Labar, D., Sperling, M. R., Sharan, A., Sandok, E., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001334 · Cited by 821
The consequences of refractory epilepsy and its treatment
Laxer, K. D., Trinka, E., Hirsch, L. J., Cendes, F., Langfitt, J., Delanty, N., Resnick, T., & Benbadis, S. R. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.05.031 · Cited by 679
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy: A Review
Jobst, B. C., & Cascino, G. D. (2015) · JAMA · doi:10.1001/jama.2014.17426 · Cited by 665
The kainic acid model of temporal lobe epilepsy
Lévesque, M., & Avoli, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.011 · Cited by 614
Epilepsy surgery in children and adults
Ryvlin, P., Cross, J. H., & Rheims, S. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70156-5 · Cited by 501
Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis
Sultana, B., Panzini, M.-A., Veilleux Carpentier, A., Comtois, J., Rioux, B., Gore, G., Bauer, P. R., Kwon, C.-S., Jetté, N., Josephson, C. B., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011839 · Cited by 435
Salanova, V., Sperling, M. R., Gross, R. E., Irwin, C. P., Vollhaber, J. A., Giftakis, J. E., Fisher, R. S., & SANTÉ Study Group (2021) · Epilepsia · doi:10.1111/epi.16895 · Cited by 333
Clinical utility of EEG in diagnosing and monitoring epilepsy in adults
Tatum, W. O., Rubboli, G., Kaplan, P. W., Mirsatari, S. M., Radhakrishnan, K., Gloss, D., Caboclo, L. O., Drislane, F. W., Koutroumanidis, M., Schomer, D. L., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.01.019 · Cited by 314
Geller, E. B., Skarpaas, T. L., Gross, R. E., Goodman, R. R., Barkley, G. L., Bazil, C. W., Berg, M. J., Bergey, G. K., Cash, S. S., Cole, A. J., et al. (2017) · Epilepsia · doi:10.1111/epi.13740 · Cited by 310
Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy
Englot, D. J., Rolston, J. D., Wright, C. W., Hassnain, K. H., & Chang, E. F. (2016) · Neurosurgery · doi:10.1227/neu.0000000000001165 · Cited by 308
Hader, W. J., Tellez‐Zenteno, J., Metcalfe, A., Hernandez‐Ronquillo, L., Wiebe, S., Kwon, C., & Jette, N. (2013) · Epilepsia · doi:10.1111/epi.12161 · Cited by 297
The management of epilepsy in children and adults
Perucca, P., Scheffer, I. E., & Kiley, M. (2018) · Medical Journal of Australia · doi:10.5694/mja17.00951 · Cited by 288
A connectomic study of a petascale fragment of human cerebral cortex
Shapson-Coe, A., Januszewski, M., Berger, D. R., Pope, A., Wu, Y., Blakely, T., Schalek, R. L., Li, P. H., Wang, S., Maitin-Shepard, J., et al. (2021) · doi:10.1101/2021.05.29.446289 · Cited by 243
Epilepsy surgery trends in the United States, 1990–2008
Englot, D. J., Ouyang, D., Garcia, P. A., Barbaro, N. M., & Chang, E. F. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d7ea · Cited by 272
Asadi-Pooya, A. A., Brigo, F., Lattanzi, S., & Blumcke, I. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01048-6 · Cited by 265
Managing drug-resistant epilepsy: challenges and solutions
Dalic, L., & Cook, M. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84852 · Cited by 258
The kainic acid models of temporal lobe epilepsy
Rusina, E., Bernard, C., & Williamson, A. (2021) · eneuro · doi:10.1523/eneuro.0337-20.2021 · Cited by 225
Management of Drug-Resistant Epilepsy
Nair, D. R. (2016) · Continuum · doi:10.1212/con.0000000000000297 · Cited by 68
Wissel, B. D., Greiner, H. M., Glauser, T. A., Holland‐Bouley, K. D., Mangano, F. T., Santel, D., Faist, R., Zhang, N., Pestian, J. P., Szczesniak, R. D., et al. (2020) · Epilepsia · doi:10.1111/epi.16398 · Cited by 61
Update on the surgical treatment of epilepsy
Jette, N., & Wiebe, S. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835ef345 · Cited by 56
Clinical Approach to Posttraumatic Epilepsy
Parko, K., & Rao, V. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1544239 · Cited by 49
Mills, J. D., van Vliet, E. A., Chen, B. J., Janitz, M., Anink, J. J., Baayen, J. C., Idema, S., Devore, S., Friedman, D., Diehl, B., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104612 · Cited by 48
Musto, A. E., Walker, C. P., Petasis, N. A., & Bazan, N. G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116543 · Cited by 39
Machine learning for predicting levetiracetam treatment response in temporal lobe epilepsy
Croce, P., Ricci, L., Pulitano, P., Boscarino, M., Zappasodi, F., Lanzone, J., Narducci, F., Mecarelli, O., Di Lazzaro, V., Tombini, M., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.08.024 · Cited by 38
Implementation of Machine Learning Pipelines for Clinical Practice: Development and Validation Study
Kanbar, L. J., Wissel, B., Ni, Y., Pajor, N., Glauser, T., Pestian, J., & Dexheimer, J. W. (2022) · JMIR Medical Informatics · doi:10.2196/37833 · Cited by 30
Low prevalence of amyloid and tau pathology in drug-resistant temporal lobe epilepsy.
Silva, J. C., Vivash, L., Malpas, C. B., Hao, Y., McLean, C., Chen, Z., O'Brien, T. J., Jones, N. C., & Kwan, P. (2021) · Epilepsia · doi:10.1111/epi.17086 · Cited by 28
Ring, A., Jacoby, A., Baker, G., Holmes, E., Hughes, D., Kierans, C., & Marson, A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.03.033 · Cited by 16
Metadata
- Authors
- Engel, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-03-07
- Volume
- 307
- Issue
- 9
- Pages
- 922
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2121709831
- Cited by
- 1,230
- References
- 37
- FWCI
- 44.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.